StockData
Carlsmed, Inc. logo

Carlsmed, Inc. (CARL) stock

CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30118% above fair value
$17.74+0.39 (+2.25%)

Close on Nov 17, 2026Market cap $484.35MP/E –Yield –

Carlsmed cash

Cash and short-term investments held at the end of each period.

Carlsmed's cash was $70.24M at Jun 30, 2026. For fiscal 2025 it was $109.79M, up 173.6% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$109.79M+173.6%
FY2024Dec 31, 2024$40.13M+455.6%
FY2023Dec 31, 2023$7.22M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$70.24M+109.9%
Q1 FY2026Mar 31, 2026$97.02M+123.4%
Q4 FY2025Dec 31, 2025$109.79M+173.6%
Q3 FY2025Sep 30, 2025$115.37M+159.6%
Q2 FY2025Jun 30, 2025$33.47M-12.3%
Q1 FY2025Mar 31, 2025$43.43M+501.4%
Q4 FY2024Dec 31, 2024$40.13M–
Q3 FY2024Sep 30, 2024$44.44M–
Q2 FY2024Jun 30, 2024$38.15M–
Q4 FY2023Dec 31, 2023$7.22M–

More Carlsmed figures

See a number that looks wrong?